<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for Calendar Year or Quarter Ended: September 30, 2000
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings
entries.
Institutional Investment Manager Filing this Report:
Name: BB Medtech AG
Address: Vordergasse 3
Grafenauweg 4
Zug, Switzerland CH-6301
Form 13F File Number: 28-6952
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables are considered integral parts of this form. Person
Signing this Report on Behalf of Reporting Manager:
Name: Dubravka Racnjak
Title: SIGNING AUTHORITY
----------------
Phone: (41-41) 724-5959
Signature, Place, and Date of Signing:
/s/ Dubravka Racnjak Zug, Switzerland November 9, 2000
<PAGE> 2
Report Type (Check only one.):
[ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
[X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
List of Other Managers Reporting for this Manager:
Name
Medcare S.A.
Medsource S.A.
Medgrowth S.A.
<PAGE> 3
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 3
Form 13F Information Table Entry Total: 9
Form 13F Information Table Value Total: $ 87,667
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
<TABLE>
<CAPTION>
No. Name
<S> <C>
1 Medcare S.A
2 Medsource S.A
3 Medgrowth S.A.
</TABLE>
<PAGE> 4
BB MEDTECH AG
FORM 13F INFORMATION TABLE
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------
COLUMN 5:
--------------------------------
COLUMN 4:
COLUMN 1: COLUMN 2: COLUMN 3: VALUE
NAME OF ISSUER TITLE OF CLASS CUSIP (X$1,000) SHRS OR SH/ PUT/
PRN AMT PRN CALL
------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Eclipsys Common Stock 278856109 $ 3,320 207,500 SH
------------------------------------------------------------------------------------------------
Durect
Corporation Common Stock 266605104 $ 10,714 714,286 SH
------------------------------------------------------------------------------------------------
Dusa
Pharmaceuticals
Inc. Common Stock 266898105 $ 7,178 233,000 SH
------------------------------------------------------------------------------------------------
Guidant Corp. Common Stock 401698105 $ 10,603 150,000 SH
------------------------------------------------------------------------------------------------
InfoCure Common Stock 45665A108 $ 3,771 950,000 SH
------------------------------------------------------------------------------------------------
Medtronic Common Stock 585055106 $ 25,553 493,210 SH
------------------------------------------------------------------------------------------------
Regeneration
Technologies,
Inc. Common Stock 75886N100 $ 2,970 360,000 SH
------------------------------------------------------------------------------------------------
Renal Care Common Stock 75993010 $ 16,520 886,750 SH
Group
------------------------------------------------------------------------------------------------
St. Jude
Medical, Inc. Common Stock 79084910 $ 7,038 138,000 SH
------------------------------------------------------------------------------------------------
COLUMN $ 87,667
TOTALS
------------------------------------------------------------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
----------------------------------------------------------------------------------------------
COLUMN 8:
COLUMN 6: COLUMN 7: VOTING AUTHORITY
INVESTMENT OTHER MANAGERS -------------------------------------
DISCRETION
COLUMN 1:
NAME OF ISSUER SOLE SHARED NONE
----------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Eclipsys DEFINED 2 207,500 NONE NONE
----------------------------------------------------------------------------------------------
Durect
Corporation DEFINED 3 714,286 NONE NONE
------------------------------------------------------------------------------------------------
Dusa
Pharmaceuticals
Inc. DEFINED 2 233,000 NONE NONE
------------------------------------------------------------------------------------------------
Guidant Corp. DEFINED 2 150,000 NONE NONE
----------------------------------------------------------------------------------------------
InfoCure DEFINED 2 950,000 NONE NONE
----------------------------------------------------------------------------------------------
Medtronic DEFINED 1 493,210 NONE NONE
----------------------------------------------------------------------------------------------
Regeneration
Technologies,
Inc. DEFINED 2 360,000 NONE NONE
------------------------------------------------------------------------------------------------
Renal Care DEFINED 1 886,750 NONE NONE
Group
----------------------------------------------------------------------------------------------
St. Jude
Medical, Inc. DEFINED 2 138,000 NONE NONE
------------------------------------------------------------------------------------------------
COLUMN
TOTALS
----------------------------------------------------------------------------------------------
</TABLE>
